SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015599
Filing Date
2018-11-13
Accepted
2018-11-09 18:30:36
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 730901
2 ex31-1.htm EX-31.1 13544
3 ex32-1.htm EX-32.1 5947
  Complete submission text file 0001493152-18-015599.txt   4903162

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE ppcb-20180930.xml EX-101.INS 720181
5 XBRL SCHEMA FILE ppcb-20180930.xsd EX-101.SCH 87566
6 XBRL CALCULATION FILE ppcb-20180930_cal.xml EX-101.CAL 48917
7 XBRL DEFINITION FILE ppcb-20180930_def.xml EX-101.DEF 215017
8 XBRL LABEL FILE ppcb-20180930_lab.xml EX-101.LAB 450532
9 XBRL PRESENTATION FILE ppcb-20180930_pre.xml EX-101.PRE 271850
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 181174375
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1